Charing Cross Hospital is an acute general teaching hospital located in Hammersmith, London, United Kingdom. The present hospital was opened in 1973, although it was originally established in 1818, approximately five miles east, in central London.

There are 511 beds in Dept. of Neurosciences Charing Cross Hospital.

During the past decade, Dept. of Neurosciences Charing Cross Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dept. of Neurosciences Charing Cross Hospital" are "Alzheimer Disease" (3 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Dept. of Neurosciences Charing Cross Hospital" in a lesser frequency.

Most popular intervention types in "Dept. of Neurosciences Charing Cross Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (2 trials), "Placebo" (2 trials), "bapineuzumab" (2 trials), "placebo" (2 trials) and "Bapineuzumab 0.5 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept. of Neurosciences Charing Cross Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dept. of Neurosciences Charing Cross Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dept. of Neurosciences Charing Cross Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Dept. of Neurosciences Charing Cross Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".